J&J and Roche Lead in S&P Ratings for Pharmaceutical Companies J&J and Roche Lead in S&P Ratings for Pharmaceutical Companies

Photo of author

By Ronald Tech

he modern architecture of business center of Johnson and Johnson, Allschwil

Johnson & Johnson (NYSE:JNJ) and Roche (OTCQX:RHHBY) have emerged as the cream of the crop among pharmaceutical giants, boasting the lowest business and financial risks based on a recent S&P Global report.

These juggernauts, J&J and Roche, excelled in terms of magnitude and blockbuster medications compared to their industry peers.


See also  Ford’s Q2 Sales Growth Challenges Amid Cyberattack and Economic Uncertainty Ford’s Q2 Sales Growth Challenges Amid Cyberattack and Economic Uncertainty